Back to search

Article

Ursodeoxycholic acid (UDCA) mitigates the host inflammatory response during <i>Clostridioides difficile</i> infection by altering gut bile acids which attenuates NF-κB signaling via bile acid activated receptors

2020-01-21

Abstract excerpt

Clostridioides difficile infection (CDI) is associated with increasing morbidity and mortality posing an urgent threat to public health. Recurrence of CDI after successful treatment with antibiotics is high, thus necessitating discovery of novel therapeutics against this enteric pathogen. Administration of the secondary bile acid ursodeoxycholic acid (UDCA, ursodiol) inhibits the life cycle of various strains of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fff66b8a-e878-5190-98e9-678ccfdf7d00
DOI
10.1101/2020.01.16.910018
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ursodeoxycholic acid (UDCA) mitigates the host inflammatory response during <i>Clostridioides difficile</i> infection by altering gut bile acids which attenuates NF-κB signaling via bile acid activated receptorsDOI 10.1101/2020.01.16.910018
Select a neighboring publication to make it the new centre.